Safer scan could replace risky biopsy for liver donors
NCT ID NCT07451379
Summary
This study aims to see if a quick, non-invasive scan (FibroScan) can be as accurate as a standard liver biopsy for measuring fat in the livers of potential living donors. Researchers will compare results from both tests in 100 adult donors to determine if the scan is a reliable alternative. The goal is to find a safer screening method that avoids the risks of biopsy, like bleeding and infection, to help expand the pool of healthy donors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-INVASIVE DONOR LIVER ASSESSMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.